Published in Circulation on February 29, 2000
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev (2011) 5.51
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42
The role of saliva in tick feeding. Front Biosci (Landmark Ed) (2009) 2.73
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood (2008) 2.36
Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26
Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med (2011) 2.12
Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood (2008) 1.93
Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells (2007) 1.92
Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A (2000) 1.90
Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling. J Exp Med (2015) 1.88
Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med (2004) 1.72
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost (2008) 1.70
Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones (2010) 1.69
Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods (2011) 1.58
Emerging roles for platelets as immune and inflammatory cells. Blood (2014) 1.56
Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol (2005) 1.55
Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol (2008) 1.51
Hyperphosphatemia, Phosphoprotein Phosphatases, and Microparticle Release in Vascular Endothelial Cells. J Am Soc Nephrol (2015) 1.43
Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 1.43
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia (2006) 1.41
Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol (2000) 1.38
Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med (2009) 1.35
Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev (2010) 1.21
Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med (2006) 1.18
Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag (2008) 1.17
Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol (2010) 1.16
The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol (2010) 1.08
Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection. Microvasc Res (2007) 1.08
Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol (1985) (2008) 1.08
Functional SNPs in HSPA1A gene predict risk of coronary heart disease. PLoS One (2009) 1.07
On the origin of microparticles: From "platelet dust" to mediators of intercellular communication. Pulm Circ (2013) 1.05
Microvesicles: novel biomarkers for neurological disorders. Front Physiol (2012) 1.04
Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis (2013) 1.03
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica (2009) 1.03
Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep (2014) 1.02
Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol (2002) 1.02
Inflammation and haemostasis. Biochem Med (Zagreb) (2012) 1.01
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib. BMC Cancer (2010) 1.01
Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy. Pol Arch Med Wewn (2010) 0.99
Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med (2012) 0.99
Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol (2006) 0.98
The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Front Immunol (2012) 0.98
Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome? Psychosomatics (2013) 0.96
MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3. Mol Cancer (2015) 0.96
Activation of blood coagulation in cancer: implications for tumour progression. Biosci Rep (2013) 0.94
The origin of circulating CD36 in type 2 diabetes. Nutr Diabetes (2013) 0.94
Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets. Mol Pharmacol (2013) 0.93
Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res (2013) 0.91
Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients. PLoS One (2014) 0.91
The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus. Arthritis Res Ther (2011) 0.90
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation. Front Genet (2014) 0.89
CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood (2014) 0.89
Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm (2010) 0.88
Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy. Thromb Res (2014) 0.88
Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction. Thromb Haemost (2007) 0.88
Serum extracellular vesicle protein levels are associated with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care (2013) 0.88
Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus. Cytometry B Clin Cytom (2013) 0.88
Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. PLoS One (2010) 0.87
Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction. Thromb J (2009) 0.87
Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes. Int Cardiovasc Res J (2014) 0.87
Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J Lipid Res (2014) 0.87
Endothelial microparticles: sophisticated vesicles modulating vascular function. Vasc Med (2013) 0.87
Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol (2012) 0.86
Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosis. Thromb J (2005) 0.86
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J Neuroinflammation (2006) 0.86
Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86
Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells. FASEB J (2016) 0.85
Levels of circulating microparticles in lung cancer patients and possible prognostic value. Dis Markers (2013) 0.85
Thrombotic microangiopathy in haematopoietic cell transplantation: an update. Mediterr J Hematol Infect Dis (2010) 0.85
Endothelial and cancer cells interact with mesenchymal stem cells via both microparticles and secreted factors. J Cell Mol Med (2014) 0.85
Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer. Biomed Res Int (2014) 0.84
The Interface between Inflammation and Coagulation in Cardiovascular Disease. Int J Inflam (2012) 0.84
Microparticles--messengers of biological information. J Cell Mol Med (2010) 0.84
Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury. J Cardiovasc Transl Res (2016) 0.84
Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation. Crit Care (2011) 0.84
Extracellular vesicles in coronary artery disease. Nat Rev Cardiol (2017) 0.84
Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss. PLoS One (2013) 0.83
Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol (2012) 0.83
Microparticles as potential biomarkers of cardiovascular disease. Arq Bras Cardiol (2015) 0.82
A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling. J Thromb Haemost (2012) 0.82
Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One (2013) 0.81
Elevated levels of procoagulant plasma microvesicles in dialysis patients. PLoS One (2013) 0.81
Increased circulating endothelial apoptotic microparticle to endothelial progenitor cell ratio is associated with subsequent decline in glomerular filtration rate in hypertensive patients. PLoS One (2013) 0.80
Retinal endothelial cell apoptosis stimulates recruitment of endothelial progenitor cells. Invest Ophthalmol Vis Sci (2009) 0.80
Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction. Arch Med Sci (2016) 0.80
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep (2016) 0.79
Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia. J Transl Med (2015) 0.79
Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands. Br J Pharmacol (2012) 0.79
The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance. Scientifica (Cairo) (2012) 0.79
4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure. Arterioscler Thromb Vasc Biol (2013) 0.79
Alteration of circulatory platelet microparticles and endothelial microparticles in patients with chronic kidney disease. Int J Clin Exp Med (2015) 0.79
A novel broadband impedance method for detection of cell-derived microparticles. Biosens Bioelectron (2010) 0.78
Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol (2011) 0.78
Circulating thrombotic and haemostatic components in patients with coronary artery disease. Indian J Clin Biochem (2010) 0.78
Procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational study. PLoS One (2014) 0.77
Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease? Blood Purif (2010) 0.77
Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome. J Clin Diagn Res (2015) 0.77
Phosphate Toxicity in CKD: The Killer among Us. Clin J Am Soc Nephrol (2016) 0.77
Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression. Scientifica (Cairo) (2016) 0.77
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem (1999) 3.57
Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J (2002) 3.56
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature (1998) 3.48
Protective role of interleukin-10 in atherosclerosis. Circ Res (1999) 3.28
Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res (2001) 3.07
Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers. J Am Coll Cardiol (1998) 2.75
Measuring circulating cell-derived microparticles. J Thromb Haemost (2004) 2.61
Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med (1996) 2.37
ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol (2000) 2.25
Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation (2001) 2.13
Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart (2008) 1.98
Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med (2006) 1.98
Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol (2000) 1.94
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation (1998) 1.90
Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation (1999) 1.89
Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood (1996) 1.89
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation (2001) 1.86
Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol (1996) 1.85
Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res (2001) 1.78
Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation (2000) 1.75
Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res (2001) 1.70
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol (2001) 1.67
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clin Pharmacol Ther (2011) 1.67
Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina. Eur Heart J (1999) 1.66
Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol (1994) 1.66
Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth (2011) 1.65
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation (2000) 1.65
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost (2001) 1.60
Microparticles and type 2 diabetes. Diabetes Metab (2008) 1.57
Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarction. J Am Coll Cardiol (1996) 1.56
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev (2011) 1.55
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res (2000) 1.55
Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model. Kidney Int (2006) 1.51
Oriented fibrin gels formed by polymerization in strong magnetic fields. Nature (1981) 1.49
Protective role of uncoupling protein 2 in atherosclerosis. Circulation (2003) 1.48
Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood (1993) 1.48
Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart (2007) 1.47
Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci (1994) 1.47
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial. Diabetes Metab Res Rev (2013) 1.47
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. Eur Heart J (1999) 1.43
The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest (1997) 1.43
[Cardiac diffusion MRI of recent and chronic myocardial infarction: preliminary results]. J Radiol (2009) 1.40
Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol (1999) 1.39
Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol (2000) 1.38
Hospital outcome after bailout coronary stenting in patients with acute myocardial infarction. Cathet Cardiovasc Diagn (1998) 1.38
Signal transduction of mechanical stresses in the vascular wall. Hypertension (1998) 1.37
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A (1998) 1.36
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation (1998) 1.35
In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation (2004) 1.29
Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol (1994) 1.29
Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats. Am J Physiol (1995) 1.27
G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation (1999) 1.26
Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res (1999) 1.25
Filtration through damaged and undamaged rabbit thoracic aorta. Am J Physiol (1984) 1.25
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol (2000) 1.22
Role of microparticles in atherothrombosis. J Intern Med (2008) 1.21
Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J Biol Chem (2000) 1.21
Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. J Biol Chem (1997) 1.18
Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis (2001) 1.17
Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res (2001) 1.17
Arterial expansive remodeling induced by high flow rates. Am J Physiol (1997) 1.17
Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood (1999) 1.16
Effects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. Circ Res (1996) 1.11
Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation (2000) 1.11
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. Int J Cardiol (2010) 1.11
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest (1996) 1.10
Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5'-monophosphate. Am J Respir Crit Care Med (1998) 1.07
Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation (1997) 1.06
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest (1999) 1.05
Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry (1995) 1.05
Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart (2002) 1.04
Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation (2001) 1.03
An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis. Thromb Haemost (1986) 1.03
Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol (1991) 1.02
Are the results of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction different during the "off" hours? Am J Cardiol (1997) 1.02
A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol (2000) 1.01
Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation (2001) 1.01
Differential effects of pressure and flow on DNA and protein synthesis and on fibronectin expression by arteries in a novel organ culture system. Circ Res (1995) 1.01
Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. J Clin Invest (2001) 1.00
Human factor VIII procoagulant activity and phospholipid interaction. Biochim Biophys Acta (1981) 1.00
Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol (1997) 1.00
Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med (2008) 0.99
Age and gender effects on cardiomyocyte apoptosis in the normal human heart. J Gerontol A Biol Sci Med Sci (2001) 0.98
Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res (1996) 0.98
The interaction of convection and diffusion in the transport of 131I-albumin within the media of the rabbit thoracic aorta. Circ Res (1985) 0.97